DSIP
Delta sleep-inducing peptide, compounded as an injection.
DSIP, delta sleep-inducing peptide, is a short peptide first isolated from the blood of sleeping rabbits and studied since for its effect on sleep architecture. It is compounded as a subcutaneous injection and dispensed on a prescription.
How it works
DSIP is a neuropeptide that appears to act on the systems governing sleep and waking rather than sedating directly, which is why it is studied alongside sleep quality rather than as a sedative.
Benefits
- Studied for sleep quality and sleep onset
- Subcutaneous injection, usually taken in the evening
- Compounded to order by a licensed pharmacy
- Reviewed and prescribed by a licensed physician
Dosing protocol
As prescribed, usually in the evening. Your physician sets the amount and the schedule.
Contraindications
- Pregnancy or breastfeeding
- Taking a prescribed sedative or sleep medicine, unless your physician has reviewed it
Compounded medications are not approved by the FDA and have not been reviewed for safety, effectiveness, or quality. Medications only issued when clinically appropriate after provider evaluation.